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A B S T R A C T   
Introduction The COVID-19 pandemic has highlighted the need for robust data linkage systems and methods for identifying outbreaks of disease in near real-time. 
Objectives The primary objective of this study was to develop a real-time geospatial surveillance system to monitor the spread of COVID-19 across the UK. Methods 
Using self-reported app data and the Secure Anonymised Information Linkage (SAIL) Databank, we demonstrate the use of sophisticated spatial modelling for near- 
real-time prediction of COVID-19 prevalence at small-area resolution to inform strategic government policy areas. Results We demonstrate that using a combination 
of crowd-sourced app data and sophisticated geo-statistical techniques it is possible to predict hot spots of COVID-19 at fine geographic scales, nationally. We are also 
able to produce estimates of their precision, which is an important pre-requisite to an effective control strategy to guard against over-reaction to potentially spurious 
features of ’best guess’ predictions. Conclusion In the UK, important emerging risk-factors such as social deprivation or ethnicity vary over small distances, hence 
risk needs to be modelled at fine spatial resolution to avoid aggregation bias. We demonstrate that existing geospatial statistical methods originally developed for 
global health applications are well-suited to this task and can be used in an anonymised databank environment, thus preserving the privacy of the individuals who 
contribute their data.   
1. Introduction 
On 11th March 2020, the World Health Organization declared a 
pandemic of COVID-19 caused by the SARS-CoV-2 coronavirus [1]. By 
this date, the UK had reported 373 confirmed COVID-19 cases and six 
deaths [2]. Up to 15th July 2020, these figures had risen to 291,911 and 
45,053 [3]. Lockdowns governing the movement of the population and 
opening of shops and other facilities, initially imposed across the entire 
country on 23rd March 2020 [4], have been a key tool in the govern-
ment’s response to COVID-19. Since that date, detection of local varia-
tions in infection rates has been critical for controlling the spread of 
SARS-CoV-2 [5], including ascertaining the level of required local 
public health response across the UK. A key example of this was the 
implementation of the first ’local lockdown’ in Leicester on 30th June 
2020, in response to a cluster of COVID-19 accounting for approximately 
one in ten of all new disease cases across the country in the preceding 
week [6]. 
The COVID Symptom Study app (Zoe Global Limited, King’s College 
London) was released publicly on 24th March 2020 [7], the day after the 
UK-wide lockdown rules were first imposed. The app collects postcode 
of residence at the time of registration and daily updates on self-reported 
COVID-19-associated symptoms. The Secure Anonymised Information 
Linkage (SAIL) Databank facilitates robust secure storage and use of 
anonymised person-based data for research to improve health, 
well-being and services [8,9]. During the pandemic, SAIL has been 
receiving daily updates of the COVID Symptom Study app data, facili-
tating near real-time health surveillance of COVID-19 across the UK. 
To help understand the localised spread and flare up of the disease 
we adapted existing statistical methodology [10] for the analysis of 
geo-referenced health outcome data to map, at Lower-layer Super 
Output Area (LSOA) resolution (Datazone in Scotland and Super Output 
Area in Northern Ireland), the prevalence of positive symptom reports 
amongst app users over a rolling 14-day period, together with associated 
limits of statistical uncertainty. Notwithstanding the limitations of this 
self-reported health outcome, these maps provide the first fine-scale, 
UK-wide assessment of the geographical distribution of probable 
COVID-19 infections, and have been used by the devolved administra-
tions in each country for pandemic planning [11]. 
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2. Methods 
2.1. Population sampling 
Across the UK, as of 1st November 2020, 4,198,408 individuals had 
registered on the COVID Symptom Study app. Use of the app is voluntary 
and thus the population sample is non-random. Users of the app had to 
have access to an internet-enabled telephone, although reporting for 
multiple individuals in the same household was instigated on 1st May 
2020 for those people who could not access or use the app [12]. At the 
time of registration, individuals report baseline demographic and clin-
ical information (e.g. underlying health conditions), as well as postcode 
of residence. Self-reported data on COVID-19-associated symptoms, 
including fever and persistent cough, are recorded for any day on which 
an individual reports. For a full metadata summary see the HDR 
Gateway deposit [13]. 
The SAIL Databank acts as a secure gateway to the ZOE app data for 
the whole of the UK. Data are made available daily via a secure data 
transfer and processed into a SQL DB2 database. Access to the data is via 
a secure remote desktop login following approval for a project via an 
application to the SAIL Information Governance Review Panel (IGRP). In 
light of the COVID-19 crisis, IGRP applications were typically approved 
within 24-hours. Prior to transfer of the data to the SAIL Databank, 
postcode data were aggregated to LSOA level using the Office for Na-
tional Statistics (ONS) postcode lookup directory [14] to maintain an 
app user’s privacy. 
2.2. Informatics 
Data were extracted from the SAIL Databank using SQL and pro-
cessed to generate suitable inputs for the geospatial modelling. Where an 
individual reported their symptoms more than once in a day, the last 
record was taken. Likely instances of COVID-19 were calculated through 
either a) the presence of high fever and persistent cough (’classic 
symptoms’) or b) an algorithm developed by the King’s College team, 
which used an array of symptoms and other characteristics (persistent 
cough, skipping meals, loss of smell, gender, age and fatigue; ’multi- 
symptom algorithm’), [15]. The multi-symptom algorithm captures 
more app users who may be displaying symptoms which are not specific 
to COVID-19 (e.g. fatigue, shortness of breath, diarrhoea) and may not 
be reporting classic symptoms [15]. As a result there are noticeable 
differences in the prevalence estimates shown in Fig. 2 which vary over 
the study period. However, when taken in combination Menni et al. [15] 
have demonstrated that the multi-symptom algorithm performs well in 
predicting COVID-19 cases. The denominator of users in each LSOA for 
each analysis was calculated using a 14-day retrospective window i.e. 
the number of individuals who had reported data to the app at any time 
during that period. The numbers of app users and cases were then 
aggregated to the LSOA level. The resulting data for each LSOA consisted 
of its population-weighted centroid, x, the number of people who used 
the app at least once over the time-period in question, n, and the number 
of those who were predicted to have COVID-19 at least once within the 
time-period, y. 
2.3. Geospatial statistical model and inference 
Our statistical model is a geospatial extension of the logistic regres-
sion model for binomial (numerator/denominator) data, in which the 
log-odds of the probability, P(x), of at least one positive symptom report 
is the unobserved realisation of a spatially correlated stochastic process 
and, conditional on P(x), the corresponding numerator y follows a 
binomial distribution with denominator n. The model has three pa-
rameters that determine the mean and variance of P(x) and the rate at 
which the correlation between the values of P(x) at two different loca-
tions decays with increasing distance between them. The standard way 
to present a prevalence map is as a set of point estimates. However, point 
estimates tend to be most extreme for locations with small de-
nominators, because of their relatively sampling variation. Another 
common practice is to apply a series of tests for statistically significant 
local departures from the area-wide prevalence, with significantly large 
or small locations labelled as “hot-spots” and “cold-spots,” respectively 
[16,17]. A limitation of this approach is that statistically significant local 
departures from the area-wide average are more likely to be associated 
with large denominators, even if the size of the local departure is too 
small to be of public health significance. We argue that a more satis-
factory way to conduct prevalence mapping is as a prediction problem. 
The predictive distribution of the complete prevalence surface is its 
probability distribution conditional on all of the available data. By 
sampling from this distribution we can, a fortiori, derive a sample from 
whatever property of the prevalence surface is of interest. For the results 
presented in this paper we chose to map four summaries: the mean, a 
point prediction of prevalence; the 5% and 95% quantiles, which 
together measure the uncertainty associated with each point prediction; 
and the probability that the prevalence in the LSOA in question is greater 
than the country-wide average for each devolved nation. Arguably, If 
the primary aim of the mapping is hot-spot detection, additional useful 
summaries would be the probabilities that local prevalence exceeds each 
of a set of thresholds that would be considered large enough to trigger 
one of several possible public health responses. Patches of mapped 
probabilities close to 1 or 0 would then indicate both the geographical 
extent and magnitude of local hot-spots and cold-spots, respectively. 
We estimated the parameters using Monte Carlo maximum likeli-
hood and used the fitted model to draw samples from the joint predictive 
distribution of P(x) over all LSOA population weighted centroids. Pa-
rameters were re-estimated separately for each of the UK’s constituent 
countries, in each case using data aggregated over a rolling 14-day time- 
Fig. 1. Longitudinal trajectories of app use for each of the four UK countries up to 1st November 2020, active within a fourteen-day rolling time-window.  
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period. In the Supplementary Material we describe in detail how we 
developed and fitted the particular model that we used for our appli-
cation to the COVID-19 app data. 
The complete prediction for each LSOA is a probability distribution 
for its underlying prevalence. This distribution can be summarised as the 
user wishes. We chose to map four summaries: the mean, a point pre-
diction of prevalence; the 5% and 95% quantiles, which together mea-
sure the uncertainty associated with each point prediction; and the 
probability that the prevalence in the LSOA in question is greater than 
the country-wide average for each devolved nation, with mapped values 
close to 1 or 0 indicating “hot-spots” and “cold-spots” respectively. If the 
primary aim of the mapping is hot-spot detection, additional useful 
summaries would be the probabilities that local prevalence exceeds each 
of a set of thresholds representing increasing multiples of the country- 
wide average. Patches of mapped probabilities close to 1 would then 
indicate both the geographical extent and magnitude of local hot-spots. 
Predicted prevalence data were summarised for the whole of the UK, and 
for each of its four constituent countries. 
3. Results 
3.1. App users 
Table 1 summarises the users of the app for the UK as of 1st 
November 2020. Across the UK users were predominately female, white, 
between 30 and 55 and lived in the least deprived areas. It is also worth 
noting that the 20% of users did not provide a full postcode thereby 
limiting the utility of these users data provision for the purposes of high- 
resolution spatial modelling. 
3.2. App usage over time 
There was no national government requirement for members of the 
public to use the app. In each country, the number of people registering 
to use the system increased rapidly in the early weeks of its availability, 
and more slowly thereafter (Fig. 1). In England, Scotland and Wales the 
number of active users (people who recorded one or more app submis-
sion in the preceding 14 days) also increased between mid-April and 
early May, but declined thereafter, from a peak of around 60% in early 
May to around 45% in mid July (Fig. 1). In Northern Ireland, where the 
app is, in effect, competing with Northern Ireland’s own app [18] the 
percentage of active users peaked at around 50% in early May and had 
declined to about 30% by mid July. 
3.3. Predicted prevalence of COVID-19 over time 
Predicted disease prevalence over time, weighted for population size 
within each LSOA, was plotted using both classic symptoms and the 
multi-symptom algorithm. Both provided similar patterns of predicted 
disease prevalence for the first two weeks of data collection (Fig. 2), the 
figures from the multi-symptom algorithm were higher than those using 
classic symptoms (classic symptoms 3.6% to 4.3% across the four 
countries at their peak, multi-symptom algorithm 6.0% to 7.5%) but 
diverged thereafter. Using classic symptoms, predicted prevalence 
slowly declined to mid-May and then was approximately stable at 
slightly more than 2% in Wales, slightly less than 2% in England, 
Scotland and Northern Ireland (Fig. 2, upper panel). Using the multi- 
symptom algorithm, the decline was more rapid, stabilising around 
two weeks earlier at approximately 0.4% in all four countries (Fig. 2, 
lower panel). 
Fig. 2. Longitudinal trajectories of symptom-prevalence (percentage of active users reporting symptoms) for each of the four UK countries up to 1st November 2020, 
based on classic symptoms (upper panel) and multi-symptom algorithm (lower panel). 
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3.4. Predictive mapping 
Predictive mapping at LSOA-level geography based on inputs derived 
using the prevalence algorithm described in Menni et al.[15] revealed 
small-scale spatial variation in disease prevalence, which varied over 
time. Figures 3 and 4 show UK-wide LSOA-level maps of predicted 
prevalence and predictive probability that each LSOA exceeded the 
national average prevalence, over the pandemic to 1st November 2020. 
Most hot-spots (bright yellow areas in Fig. 4) were located in or close to 
major cities, with Aberdeen and Bristol as notable exceptions. 
Prevalence and exceedance probability maps need to be interpreted 
in combination. The prevalence exceedance (hot-spot) maps focus 
attention on areas that show statistically significant deviations above the 
national averages. However, all other things being equal, these were 
likely to occur in areas that have high population density and, conse-
quently, deliver more precise local predictions. The three-panel format 
of Fig. 5 facilitates this combined interpretation by allowing the reader 
to check whether areas indicated in Fig. 4 as hot-spots are also areas 
whose predicted prevalence is markedly high. The left-hand (5% 
quantile) and right-hand (95% quantile) panels accompanying the pre-
dicted prevalence panel act as a guard against over-interpretation of 
imprecise point predictions. For example, the centre-panel of Fig. 5 
shows that the largely rural area of west Cumbria had relatively high 
prevalence over the 14-day period ending 1st July, but the associated 
probability limits were wide, and the corresponding date in Fig. 4 does 
not indicate any part of west Cumbria to have been a hot-spot. 
Conversely, over this same period, prevalence levels in London were 
no longer among the highest in the country (Fig. 5, centre panel), but 
were nevertheless almost certainly above the English national average 
(Fig. 4) and therefore a hotspot. 
4. Discussion 
The COVID-19 pandemic has shown how a combination of skills 
(Health Informatics, Statistics and Geography) can provide insights to 
inform local and national government policy at a UK level. Building on 
the HDR UK ’One Institute’ principles, we have prototyped and deliv-
ered data infrastructures and analysis pipelines capable of delivering 
timely and insightful analytics to all levels of government. These have 
formed a cornerstone of the COVID-19 response in Scotland and Wales in 
particular, and illustrate how fine-grained spatio-temporal inferential 
mapping tools for near-real-time crowd-sourced georeferenced health 
outcome data are critical to inform rapid public health responses. 
The platform established within the SAIL system should not be seen 
as uniquely applicable to data from the COVID Symptom Study app, or 
indeed to COVID-19. Such tools can be applied to any source of geore-
ferenced health data, including when comparing data sourced via 
different detection and testing platforms, each of which may have a 
different target population, sensitivity and specificity. We note the 
particular relevance to newly emerging infectious conditions – where 
spatiotemporal mapping of spread is critical – and thus the need to 
maintain such platforms so that they can be activated as each pandemic 
arises, e.g. for influenza [19]. The required geospatial methodology for 
these tools has been available since the early years of the century [20]. 
Diggle et al. [21] report on a real-time surveillance system for calls to the 
now-defunct NHS Direct on-line triage service [22] for which the pri-
mary reason for the call was recorded as non-specific gastro-intestinal 
illness. This system was developed in collaboration with the South-
ampton Public Health Service and ran in prototype form over the years 
2001 to 2003. 
There has been a proliferation of mapped outputs related to the 
COVID-19 pandemic with policy makers and the general public equally 
concerned with tracking the pandemic. However, most of the published 
maps have been at a regional level [7,5,23]. Although valuable, these 
can mask localised hotspots as exemplified by the Leicester, UK 
outbreak. In situations where expedient decisions are required, mapping 
statistical outputs to granular geographies, with supporting information 
relating to confidence intervals, gives policy makers better information 
to take necessary action. Also, by recognising and exploiting spatial 
correlation in the underlying prevalence surface, geospatial statistical 
methods can deliver substantially more precise estimation of local 
prevalence than classical methods that implicitly assume independence 
of outcomes in different spatial units [24]. 
There is an extensive literature on statistical models for geo- 
referenced prevalence data. All exploit the fact that in the presence of 
spatial correlation, prevalence data from any location are partially 
predictive of prevalence at nearby locations. The most important way in 
which they differ is the spatial scale on which they operate. Spatially 
discrete, Markov random field models [25,26] are widely used to 
construct disease atlases from data recorded as case-counts and de-
nominators from a set of administrative regions that partition the area of 
interest. They typically define the spatial dependence amongst regions 
by their contiguities. In contrast, geostatistical models [10] and point 
process models [27,28] are spatially continuous and define spatial 
dependence between locations as a function of their distance apart. 
Geostatistical models treat the data as case-counts and denominators 
from a set of sampling locations within the area of interest, whereas 
point process models require individual cases to be accurately geore-
ferenced; for example, by full UK post-code. In our case, we could have 
used individual case data but preferred to aggregate to LSOA-level to 
Table 1 
Summary of registered ZOE Symptom Study App users as of 1st November 2020.   
Number Percentage 
Registered app users 4198408 100.0%  
Age   
Median (IQR) 40 (30,55)  
0–10 192431 4.6% 
15–20 378000 9.0% 
25–30 728487 17.4% 
35–40 762011 18.1% 
45–50 720108 17.2% 
55–60 584101 13.9% 
65–70 368274 8.8% 
75–80 100750 2.4% 
85+ 23529 0.6% 
Not Recorded 330717 7.9%  
Gender   
Female 2342803 55.8% 
Male 1521609 36.2% 
Prefer not to say 3014 0.1% 
Intersex 301 < 0.1%  
Not Recorded 330681 7.9%  
Ethnicity   
Hispanic 64 0.0% 
Other 13961 0.3% 
Prefer not to say 12371 0.3% 
Asian (UK) 64894 1.5% 
Black (UK) 18176 0.4% 
Chinese 10999 0.3% 
Middle Eastern 11709 0.3% 
Mixed (other) 36736 0.9% 
Mixed (White/Black) 18974 0.5% 
White (UK) 2817129 67.1% 
US Residents 2163 0.1% 
Not Recorded 1191232 28.4%  
Deprivation (Townsend Quintile)   
1. Least Deprived 924910 22.0% 
2 837050 19.9% 
3 702876 16.7% 
4 544344 13.0% 
5. Most Deprived 429120 10.2% 
Not Recorded 760108 18.1%  
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Fig. 3. LSOA Level COVID-19 prevalence predictions using a 14-day window 1st May – 1st November 2020. Purples represent low values, green mid range and 
yellow high values. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.) 
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Fig. 4. Predictive probabilities for LSOA-level prevalence to exceed the UK-wide average using a 14-day window 1st May – 1st November 2020. Purples represent 
low probabilities, green mid range and yellow high probabilities. (For interpretation of the references to color in this figure legend, the reader is referred to the web 
version of this article.) 
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acknowledge that, even in lockdown, most members of the population 
were not rigidly confined to their homes. However, we did not want to 
use contiguities to determine spatial dependence because of the very 
wide variation in the geographical sizes of LSOAs in different parts of the 
UK. For these reasons, we analysed the data using a geostatistical model 
with population-weighted LSOA centroids as the nominal sampling 
locations. 
The use of predictive probability mapping is an important feature of 
our approach as it enables the production of maps that relate directly to 
public health policy. This concept is well-established in control pro-
grammes for a number of neglected tropical diseases; for example, WHO 
guidelines [29] for prophylactic treatment of soil-transmitted helminth 
infections specify different levels of continued treatment according to 
the exceedance or not of a set of agree prevalence thresholds. At the time 
of writing, the UK uses a “tiered” system of Covid risk-levels to deter-
mine what restrictions are in place in each part of the country, but the 
criteria for allocating tier membership are opaque with large adminis-
trative boundaries used to define which communities are included. 
We acknowledge the limitations that come with using self-reported 
symptom data from an app used voluntarily. Firstly, confirmation that 
self-reported symptoms did indeed represent COVID-19 disease was not 
possible at a UK level, although the multi-symptom algorithm utilised 
was generated using predictive regression modelling comparing symp-
toms to self-reported reverse transcription polymerase chain reaction 
SARS-CoV-2 test results [15]. Secondly, the individuals included in the 
studied population are not a random sample of the UK population, 
potentially presenting a source of collider bias due to the link between 
age and app usage [30], nor are they necessarily representative with 
respect to other factors that are either known, or thought likely, to affect 
susceptibility; for example, gender or ethnicity. The inclusion in the 
model of LSOA-level covariate information is a potential route to con-
trolling for these at LSOA level, although not at individual level. For 
example, in the current COVID-19 context information on the age dis-
tribution of app users would allow adjustment for the potentially 
non-representative sub-population of active app users. For environ-
mentally driven health outcomes, such as asthma symptom exacerbation 
in relation to air quality, covariate adjustment could also materially 
improve predictive precision. In this paper we use repeated 
cross-sectional analysis of the app data to visualise change in prevalence 
across the UK. However, other approaches which borrow information 
over time as well as space [31,32], could be considered when measuring 
longitudinal change in predicted prevalence. 
This combination of real-time data sources and rapid analytical tools 
using readily adaptable methodologies is a powerful one in the control 
of pathogens where evolving spatio-temporal patterns of incidence are 
of public health concern. Our response to COVID-19 has much to teach 
us about preparedness for the next pandemic [19,33]. 
5. Conclusions 
In conclusion, we have demonstrated the value of a real-time spatio- 
temporal inferential mapping platform for public health efforts during 
the emergence and spread of infectious diseases. The work has been 
conducted in the confines of the privacy-protecting SAIL Databank to 
produce statistically robust results at a spatially granular level whilst 
ensuring that no individual contributor to the ZOE Symptom Study app 
can be identified. Such tools are not only essential to produce 
population-weighed estimates of disease prevalence, but they provide a 
unique insight into the geographical distribution of the disease, thus 
informing local and national control efforts. 
Summary points 
What is known? 
• COVID-19 has highlighted the need for robust methods for identi-
fying outbreaks of disease and local levels.  
• Most mapping efforts have so far been restricted to regional level 
estimates – there are very few local level estimates of COVID-19 
prevalence.  
• Self reported app data is currently being contributed by 4 million 
people in the UK. 
What we are adding?  
• We demonstrate the use of sophisticated spatial modelling for near- 
real-time prediction of COVID-19 prevalence at small-area resolution 
to inform strategic government policy areas. 
Fig. 5. Predicted (lower 5% (left-hand panel (a)), mean (centre-panel (b)), and upper 95% (right-hand panel (c))) limits for the LSOA-level prevalence over the 14- 
day period ending 1st July 2020. Purples represent low values, green mid range and yellow high values. Maps coloured using Jenks Natural Breaks algorithm to 
highlight differences. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.) 
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• We provide estimates of their precision, to guard against over- 
reaction to potentially spurio us features of /’best guess/’ 
predictions.  
• We demonstrate that adapting existing geospatial statistical 
methods, originally developed for global health applications, can be 
used in an anonymised databank environment, thus preserving the 
privacy of the individuals who contribute their data. 
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